Modified amino acids
US-9682934-B2 · Jun 20, 2017 · US
US10112900B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10112900-B2 |
| Application number | US-201715600632-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 19, 2017 |
| Priority date | Aug 31, 2012 |
| Publication date | Oct 30, 2018 |
| Grant date | Oct 30, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are modified amino acids comprising an azido group, polypeptides, antibodies and conjugates comprising the modified amino acids, and methods of producing the polypeptides, antibodies and conjugates comprising the modified amino acids. The polypeptides, antibodies and conjugates are useful in methods of treatment and prevention, methods of detection and methods of diagnosis.
Opening claim text (preview).
What is claimed is: 1. A compound according to formula I: or a salt thereof, wherein: D is Ar—W 3 — or —W 1 —Y 1 —C(O)—Y 2 —W 2 —; Ar is each of W 1 , W 2 , and W 3 is independently a single bond or lower alkylene; X 1 is —O— or —S—; Y 1 is a single bond, —NH—, or —O—; Y 2 is an N-linked or C-linked divalent pyrrolidine radical; and one of Z 1 , Z 2 , and Z 3 is —N— and the others of Z 1 , Z 2 , and Z 3 are independently —CH—. 2. The compound of claim 1 , wherein D is —Ar—W 3 —. 3. The compound of claim 1 , wherein D is —W 1 —Y 1 —C(O)—Y 2 —W 2 —. 4. The compound of claim 1 , wherein: D is —Ar—W 3 —; and Ar is 5. The compound of claim 1 , wherein: D is —Ar—W 3 —; and Ar is 6. The compound of claim 1 , wherein: D is —Ar—W 3 —; W 3 is —CH 2 —; and Ar is 7. The compound of claim 1 wherein: D is —W 1 —Y 1 —C(O)—Y 2 —W 2 —; and Y 1 is —NH— or —O—. 8. The compound of claim 1 , wherein: D is —W 1 —Y 1 —C(O)—Y 2 —W 2 —; and W 2 is a single bond. 9. The compound of claim 1 according to formula Ia: 10. The compound of claim 1 , wherein each of W 2 and W 3 is independently C 1 -C 3 alkylene. 11. The compound of claim 1 according to any of formulas (1)-(5), (7)-(17), (24)-(29), and 40: or a salt thereof. 12. A compound according to formula II: or a salt thereof, wherein W 4 is C 1 -C 10 alkylene. 13. The compound of claim 12 according to formula 30: or a salt thereof.
Immunomodulators · CPC title
Antineoplastic agents · CPC title
Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] · CPC title
Granulocyte CSF; Granulocyte-macrophage CSF · CPC title
to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.